Concepedia

Publication | Closed Access

LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation

74

Citations

0

References

2021

Year

No additional data available for this publication yet. Check back later!